Verona Pharma plc (VRNA) Reports In-Line Q3 EPS
Verona Pharma plc (NASDAQ: VRNA) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07).
For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.
Verona Pharma plc (NASDAQ: VRNA) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07).
For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.